| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| MCBC Holdings (tba) | Baird/ Raymond James/ Wells Fargo Securities | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| tba (to be announced) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Azure Midstream Partners, LP (AZUR) | Citigroup/ BofA Merrill Lynch | $175.00 | n.a. | |||
| New Terms | ||||||
| 8point3 Energy Partners LP (CAFD) | Goldman Sachs/ Citigroup | $50.00 | n.a. | |||
| Adaptimmune Therapeutics PLC (ADAP) | BofA Merrill Lynch/ Cowen and Company/ Leerink Partners | 9.38 | $15.00 | $17.00 | $150.00 | 3-Stars |
| Anterios (ANTE) | Stifel/ RBC | 3.90 | $12.00 | $14.00 | $50.70 | 1-Star |
| Arcadia Biosciences (RKDA) | Credit Suisse/ J.P. Morgan/ Piper Jaffray | 7.15 | $13.00 | $15.00 | $100.10 | n.a. |
| aTYR PHARMA (LIFE) | J.P. Morgan/ Citigroup | 5.36 | $13.00 | $15.00 | $75.04 | 2-Stars |
| Bojangles (BOJA) | BofA Merrill Lynch/ Wells Fargo Securities/ Jefferies | 6.25 | $15.00 | $17.00 | $100.00 | 3-Stars |
| Collegium Pharmaceutical (COLL) | Jefferies/ Piper Jaffray | 5.80 | $12.00 | $14.00 | $75.40 | 1-Star |
| Commercial Credit (CCR) | J.P. Morgan/ Keefe, Bruyette & Woods (A Stifel Company) | 7.25 | $15.00 | $17.00 | $116.00 | 2-Stars |
| Fenix Parts (FENX) | BMO Capital Markets/ Stifel | 11.00 | $9.00 | $11.00 | $110.00 | n.a. |
| HTG Molecular Diagnostics (HTGM) | Leerink Partners | 3.57 | $13.00 | $15.00 | $49.98 | 2-Stars |
| International Market Centers (IMC) | Barclays/ Credit Suisse/ Wells Fargo Securities | 11.50 | $12.00 | $14.00 | $149.50 | 1-Star |
| Klox Technologies (KLOX) | UBS Investment Bank | 4.80 | $13.00 | $15.00 | $67.20 | 1-Star |
| Tallgrass Energy GP, LP (TEGP) | Citigroup/ Goldman Sachs | 35.31 | $24.00 | $27.00 | $900.43 | 3-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 27, 2015 | Manager(s) | Offered | Raised | Price | 5/1/15 | Change |
| Viking Therapeutics (VKTX) | Laidlaw & Company (UK) Ltd. | 3.00 | $24.00 | $8.00 | $9.10 | 13.75% |
| Enviva Partners, LP (EVA) | Barclays/ Goldman Sachs/ RBC Capital Markets/ Citigroup | 10.00 | $200.00 | $20.00 | $21.19 | 5.95% |
| Blueprint Medicines (BPMC) | Goldman Sachs/ Cowen and Company | 8.15 | $146.63 | $18.00 | $18.53 | 2.94% |
| Atlantic Alliance Partnership (AAPC) | Citigroup | 7.50 | $75.00 | $10.00 | $10.09 | 0.90% |
| Arowana (ARWAU) (u) | EarlyBirdCapital | 7.20 | $72.00 | $10.00 | $10.02 | 0.20% |
| Black Stone Minerals, L.P. (BSM) | Barclays/ BofA Merrill Lynch/ Citigroup/ Credit Suisse/ Wells Fargo Securities | 22.50 | $427.50 | $19.00 | $18.24 | -4.00% |
